The Fox Tales

Main Menu

  • Home
  • Novel update
  • Novel books
  • Novel story
  • Novel list

The Fox Tales

The Fox Tales

  • Home
  • Novel update
  • Novel books
  • Novel story
  • Novel list
Novel update
Home›Novel update›Pfizer and Moderna to ‘update’ vaccines against new, highly infectious variants, WHO warns

Pfizer and Moderna to ‘update’ vaccines against new, highly infectious variants, WHO warns

By Jack N. Hernandez
November 27, 2021
0
0


Pfizer & BioNTech and Moderna have expressed their willingness to “update” their vaccines to work better with protection against new variants in development that would have been worse than previous ones. The world is known to be healing because many of its citizens have been vaccinated and have developed immunity to COVID-19, but variants are developing for the worse.

Pfizer and Moderna to ‘Update Vaccines’ Against New WHO Variant

(Photo: Unsplash / Braňo)
Covid-19 vaccine

CNBC TechCheck report received a note from the two mRNA vaccine developers, Pfizer & BioNTech, and Moderna for their willingness to “update” their vaccines for new variants made available to the public. The vaccine may be in booster form for those who have already received vaccine injections earlier this year.

However, it has not been discussed whether it could act as the first two comprehensive COVID-19 vaccines for those who have not yet been immunized against the virus. Pfizer and Moderna are known to be the most active companies in updating their vaccines, providing boosters to boost people’s immunity and improve lives.

Read also: Hundreds of Google Employees Oppose Company’s Covid Vaccination Mandate

South African variant: how bad is it?

The South African variant is just one of two variants that the World Health Organization (WHO) has warned against, especially since there are many that are currently under study. . According to the Daily Mail, the one from South Africa is called “Nu” and the more extreme one from Belgium, “Omicron”, aka “B.1.1.529”, is known as a super mutation.

COVID-19 mRNA vaccines

Pfizer and BioNTech’s vaccine against the global virus that triggered a pandemic is currently the only vaccine approved by the FDA on the market, making it one of the best protections against COVID-19. This is followed by another mRNA-based vaccine made by Moderna which is also seeking its FDA approval, not just its current request for EUA or emergency use.

Covid-19 vaccine

(Photo: GettyImages / ISHARA S. KODIKARA)
Florida COVID-19 vaccine

The new mRNA approach is known to have been the reason for the success of these COVID-19 vaccines, something that has changed the way it has been developed in recent years. There have been opinions regarding mRNA vaccines, with some claiming that it is “the future of vaccines” because of its rapid influence on antibodies in the body.

The goal of mRNA vaccines is to provide rapid-acting antibody replication in the body that is different from the traditional adenovirus focus which uses a similar but weakened virus to inform the antibodies what to protect. Nonetheless, COVID continues to mutate into different and stronger variants, and humans must also improve their level of protection against it with vaccine updates.

Associated article: New COVID-19 variant detected in South Africa; Has twice as many mutations as Delta

This article is the property of Tech Times

Written by Isaiah Richard

2021 TECHTIMES.com All rights reserved. Do not reproduce without permission.



Related posts:

  1. Nigeria COVID-19 Update – Nairametrics
  2. Cassava Sciences, Inc. (NASDAQ: SAVA) Short Interest Update
  3. Bridgerton Season 2 Release: Showrunner Sparks Frenzy with Netflix Drama Update | Television and radio | Show biz & TV
  4. COVID-19 update for November 25: here are the latest news on the coronavirus in British Columbia
Previous Article

Why Modi won’t be happy with the ...

Next Article

Column: 10 books to end fall

  • Privacy Policy
  • Terms and Conditions